Retraction notices

Efficacy of Neoadjuvant Chemotherapy with Epirubicin and Cyclophosphamide and Weekly Paclitaxel and Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Carcinoma: A Real-World Study

Type

Retraction

Notice date

3/20/2024 0:00

Journal

BioMed Research International

Publisher

Wiley

Notice DOI

10.1155/2024/9785671

Original paper DOI

10.1155/2020/3208391

Reasons

• Computer-Aided Content or Computer-Generated Content
• Concerns/Issues about Data
• Concerns/Issues about Referencing/Attributions
• Concerns/Issues about Results and/or Conclusions
• Concerns/Issues about Peer Review
• Investigation by Journal/Publisher
• Investigation by Third Party
• Paper Mill
• Unreliable Results and/or Conclusions

Matching venue names

Name match only, not an authoritative journal identifier.

• BioMed Research International